Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Should FDA Make Patients Care About A Problem If They Don’t Already?

Executive Summary

FDA’s Risk Communication Advisory Committee discusses best ways to communicate uncertainty, including how aggressive FDA should be with groups that are not engaged in its messages.

You may also be interested in...



Risk Communication Panel To Continue Discussion Of Uncertainty Messaging

FDA looking for more help from advisory committee on how much information about uncertainty to give as well as how best to communicate it to minority, uneducated groups.

Can't Please Everybody: FDA's "Brief Summary" Redesign May Require Flexibility

Drug Facts Box format scored well in a broad study, but researchers found it may not be the best format for everyone.

Postmarketing Trial For Horizon Thyroid Eye Drug Tepezza To Be Larger Than Expected

Horizon CEO says safety trial will be conducted in a larger patient population following discussions during the US FDA advisory committee meeting.

Topics

UsernamePublicRestriction

Register

PS054578

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel